Chemoinformaics analysis of 2-Methyl-2-butene
| Molecular Weight | 70.135 | nRot | 0 |
| Heavy Atom Molecular Weight | 60.055 | nRig | 1 |
| Exact Molecular Weight | 70.0782 | nRing | 0 |
| Solubility: LogS | -2.554 | nHRing | 0 |
| Solubility: LogP | 2.968 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 5 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 15.0179 |
| nHD | 0 | BPOL | 10.0321 |
| QED | 0.382 |
| Synth | 2.437 |
| Natural Product Likeliness | 1.406 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.007 |
| HIA | 0.005 |
| CACO-2 | -4.248 |
| MDCK | 0.000024 |
| BBB | 0.984 |
| PPB | 0.828319 |
| VDSS | 2.361 |
| FU | 0.177608 |
| CYP1A2-inh | 0.899 |
| CYP1A2-sub | 0.632 |
| CYP2c19-inh | 0.206 |
| CYP2c19-sub | 0.872 |
| CYP2c9-inh | 0.032 |
| CYP2c9-sub | 0.511 |
| CYP2d6-inh | 0.033 |
| CYP2d6-sub | 0.325 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.243 |
| CL | 13.536 |
| T12 | 0.673 |
| hERG | 0.015 |
| Ames | 0.011 |
| ROA | 0.022 |
| SkinSen | 0.405 |
| Carcinogencity | 0.066 |
| EI | 0.994 |
| Respiratory | 0.101 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.948376 |